Physician profile
Ryan Anderson
NPI 1942349329
$3,812.37
in general payments reported to CMS, 2019-2025
9 companies · $133 in 2025
The $133 reported for 2025 was more than what a typical Periodontics provider received nationally (typical 2025 total: $111).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $140 · 2020: $21.22 · 2021: $396 · 2022: $2,231 · 2023: $503 · 2024: $387 · 2025: $133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Entertainment: $822 · Food and Beverage: $202.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Entertainment | $821.69 |
| Food and Beverage | $201.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Keystone Dental INC. | $3,162.69 | 2019-2025 | |
| Biohorizons Implant Systems INC. | $327.60 | 2021-2025 | Biohorizons, Biohorizons Dental Implants |
| Straumann USA LLC | $141.95 | 2022-2024 | |
| Zest Holdings, LLC | $47.69 | 2021 | |
| Patterson Companies, INC. | $43.96 | 2023 | |
| Zimmer Biomet Holdings, INC. | $41.18 | 2021 | |
| Dentsply Ih INC. | $17.12 | 2019 | |
| Geistlich Pharma, North America, INC. | $16.67 | 2021 | |
| Dentsply Sirona INC | $13.51 | 2023 | Cavitron |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Anderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.